These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 11703656)

  • 1. Arylamine N-acetyltransferase of Mycobacterium tuberculosis is a polymorphic enzyme and a site of isoniazid metabolism.
    Upton AM; Mushtaq A; Victor TC; Sampson SL; Sandy J; Smith DM; van Helden PV; Sim E
    Mol Microbiol; 2001 Oct; 42(2):309-17. PubMed ID: 11703656
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mutational and expression analysis of tbnat and its response to isoniazid.
    Sholto-Douglas-Vernon C; Sandy J; Victor TC; Sim E; Helden PD
    J Med Microbiol; 2005 Dec; 54(Pt 12):1189-1197. PubMed ID: 16278433
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structural investigation of mutant Mycobacterium smegmatis arylamine N-acetyltransferase: a model for a naturally occurring functional polymorphism in Mycobacterium tuberculosis arylamine N-acetyltransferase.
    Kawamura A; Sandy J; Upton A; Noble M; Sim E
    Protein Expr Purif; 2003 Jan; 27(1):75-84. PubMed ID: 12509987
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence towards the role of arylamine N-acetyltransferase in Mycobacterium smegmatis and development of a specific antiserum against the homologous enzyme of Mycobacterium tuberculosis.
    Payton M; Gifford C; Schartau P; Hagemeier C; Mushtaq A; Lucas S; Pinter K; Sim E
    Microbiology (Reading); 2001 Dec; 147(Pt 12):3295-302. PubMed ID: 11739761
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cloning and characterization of arylamine N-acetyltransferase genes from Mycobacterium smegmatis and Mycobacterium tuberculosis: increased expression results in isoniazid resistance.
    Payton M; Auty R; Delgoda R; Everett M; Sim E
    J Bacteriol; 1999 Feb; 181(4):1343-7. PubMed ID: 9973365
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Arylamine N-acetyltransferases: from structure to function.
    Sim E; Walters K; Boukouvala S
    Drug Metab Rev; 2008; 40(3):479-510. PubMed ID: 18642144
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Variants of katG, inhA and nat genes are not associated with mutations in efflux pump genes (mmpL3 and mmpL7) in isoniazid-resistant clinical isolates of Mycobacterium tuberculosis from India.
    Unissa AN; Dusthackeer VNA; Kumar MP; Nagarajan P; Sukumar S; Kumari VI; Lakshmi AR; Hanna LE
    Tuberculosis (Edinb); 2017 Dec; 107():144-148. PubMed ID: 29050763
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polymorphism p.Val231Ile alters substrate selectivity of drug-metabolizing arylamine N-acetyltransferase 2 (NAT2) isoenzyme of rhesus macaque and human.
    Tsirka T; Boukouvala S; Agianian B; Fakis G
    Gene; 2014 Feb; 536(1):65-73. PubMed ID: 24333853
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Arylamine N-acetyltransferases in mycobacteria.
    Sim E; Sandy J; Evangelopoulos D; Fullam E; Bhakta S; Westwood I; Krylova A; Lack N; Noble M
    Curr Drug Metab; 2008 Jul; 9(6):510-9. PubMed ID: 18680471
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The structure of arylamine N-acetyltransferase from Mycobacterium smegmatis--an enzyme which inactivates the anti-tubercular drug, isoniazid.
    Sandy J; Mushtaq A; Kawamura A; Sinclair J; Sim E; Noble M
    J Mol Biol; 2002 May; 318(4):1071-83. PubMed ID: 12054803
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Arylamine N-acetyltransferases: from drug metabolism and pharmacogenetics to drug discovery.
    Sim E; Abuhammad A; Ryan A
    Br J Pharmacol; 2014 Jun; 171(11):2705-25. PubMed ID: 24467436
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Arylamine N-acetyltransferases: a pharmacogenomic approach to drug metabolism and endogenous function.
    Sim E; Pinter K; Mushtaq A; Upton A; Sandy J; Bhakta S; Noble M
    Biochem Soc Trans; 2003 Jun; 31(Pt 3):615-9. PubMed ID: 12773167
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Detection of mutation in NAT II gene as a method of determination of izoniazyd (INH) acetylation type in human population].
    Augustynowicz-Kopeć E; Zabost A; Kozińska M; Brzezińska S; Zwolska Z
    Pneumonol Alergol Pol; 2007; 75(2):134-9. PubMed ID: 17973219
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Binding of the anti-tubercular drug isoniazid to the arylamine N-acetyltransferase protein from Mycobacterium smegmatis.
    Sandy J; Holton S; Fullam E; Sim E; Noble M
    Protein Sci; 2005 Mar; 14(3):775-82. PubMed ID: 15722451
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Arylamine N-acetyltransferase is required for synthesis of mycolic acids and complex lipids in Mycobacterium bovis BCG and represents a novel drug target.
    Bhakta S; Besra GS; Upton AM; Parish T; Sholto-Douglas-Vernon C; Gibson KJ; Knutton S; Gordon S; DaSilva RP; Anderton MC; Sim E
    J Exp Med; 2004 May; 199(9):1191-9. PubMed ID: 15117974
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Divergence of cofactor recognition across evolution: coenzyme A binding in a prokaryotic arylamine N-acetyltransferase.
    Fullam E; Westwood IM; Anderton MC; Lowe ED; Sim E; Noble ME
    J Mol Biol; 2008 Jan; 375(1):178-91. PubMed ID: 18005984
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interaction of wild type, G68R and L125M isoforms of the arylamine-N-acetyltransferase from Mycobacterium tuberculosis with isoniazid: a computational study on a new possible mechanism of resistance.
    Ramos RM; Perez JM; Baptista LA; de Amorim HL
    J Mol Model; 2012 Sep; 18(9):4013-24. PubMed ID: 22460521
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NMR investigation of the catalytic mechanism of arylamine N-acetyltransferase from Salmonella typhimurium.
    Delgoda R; Lian LY; Sandy J; Sim E
    Biochim Biophys Acta; 2003 Mar; 1620(1-3):8-14. PubMed ID: 12595067
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monomorphic and polymorphic human arylamine N-acetyltransferases: a comparison of liver isozymes and expressed products of two cloned genes.
    Grant DM; Blum M; Beer M; Meyer UA
    Mol Pharmacol; 1991 Feb; 39(2):184-91. PubMed ID: 1996083
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolic activation and deactivation of arylamine carcinogens by recombinant human NAT1 and polymorphic NAT2 acetyltransferases.
    Hein DW; Doll MA; Rustan TD; Gray K; Feng Y; Ferguson RJ; Grant DM
    Carcinogenesis; 1993 Aug; 14(8):1633-8. PubMed ID: 8353847
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.